Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion

Retina

Volumn 21, Issue 2, 2001, Pages 161-166

  Johnson, T Mark ^a,b,c   El defrawy, S ^a,b,c   Hodge, W G ^a,b,c   Leonard, B C ^a,b,c   Kertes, P J ^a,b,c   Taylor, S A M ^a,b,c   Lillicrap, D P ^a,b,c  

^a UNIVERSITY OF OTTAWA EYE INSTITUTE   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

^c KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Activated protein C resistance; Central retinal vein occlusion; Factor V Leiden

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; CASE CONTROL STUDY; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; RISK FACTOR; SCREENING TEST;

EID: 0035048062     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200104000-00010     Document Type: Article

References (24)

1. Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases
2. Risk factors for central retinal vein occlusion
3. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
4. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
5. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men
6. Resistance to activated protein C as a basis for venous thrombosis
7. Central retinal vein thrombosis associated with resistance to activated protein C
8. Thromboses veineuses oculaires: Relation avec la mutation G169lA sur le gene du facteur V
9. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance
10. Increased frequency of factor V gene mutation associated with resistance to activated protein C in patients with retinal vascular occlusion
11. Blood viscosity, coagulation and activated protein C resistance in central retinal vein occlusion: A population controlled study
12. Activated protein C resistance in young adults with central retinal vein occlusion
13. Prevalence of factor V Leiden in young adults with retinal vein occlusion
14. Factor V and antithrombin mutations in patients with idiopathic central retinal vein occlusions
15. Factor V Leiden, activated protein C resistance and retinal vein occlusion
16. Activated protein C resistance, factor V Leiden and central retinal vein occlusion
17. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions
18. A randomized clinical trial of early panretinal photocoagulation for ischemic central retinal vein occlusion
19. Prevalence of factor V Leiden in a Canadian blood donor population
20. APC resistance and Mnl genotype (Gln 506) of coagulation factor V are rare in Japanese population
21. Identification of the same factor V gene mutation in 47 out of 50 thrombosis prone families with inherited resistance to activated protein C
22. Influence of storage conditions on activated protein C resistance assay
23. Regulatory mechanisms in hemostasis: Natural anticoagulants
24. Estimating sample size and power